Evaluation and management of urinary tract infections in the neonate

Current Opinion in Pediatrics

Volumn 24, Issue 2, 2012, Pages

  Beetz, Rolf ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

antibacterial therapy; neonate; prophylaxis; urinary tract infection; vesicoureteral reflux

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CEPHALOSPORIN; COTRIMOXAZOLE; GENTAMICIN; INTERLEUKIN 8; PLACEBO; PROCALCITONIN; SUCCIMER;

ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; BACTERIUM CONTAMINATION; BLADDER CATHETERIZATION; BLADDER PUNCTURE; BLOOD CULTURE; CANDIDA; CIRCUMCISION; CLINICAL EVALUATION; CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DILATATION; DRUG EFFICACY; EARLY INTERVENTION; ECHOGRAPHY; ENTEROBACTER; ERYTHROCYTE SEDIMENTATION RATE; ESCHERICHIA COLI; FEEDING DISORDER; FEVER; FOLLOW UP; GRUNTING; HOSPITAL INFECTION; HOSPITAL READMISSION; HUMAN; HYDRONEPHROSIS; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; INTRAVENOUS ADMINISTRATION; JAUNDICE; KIDNEY INJURY; KIDNEY PARENCHYMA; KIDNEY SCINTISCANNING; KLEBSIELLA PNEUMONIAE; LETHARGY; LEUKOCYTE COUNT; LONG TERM CARE; MICTURITION CYSTOURETHROGRAPHY; NEWBORN INFECTION; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS; PYELONEPHRITIS; RECURRENT INFECTION; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SYMPTOM; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT INDICATION; URETEROPELVIC JUNCTION OBSTRUCTION; URINALYSIS; URINARY TRACT DILATATION; URINARY TRACT DISEASE; URINARY TRACT INFECTION; URINE LEVEL; VESICOURETERAL REFLUX;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BIOLOGICAL MARKERS; DIAGNOSTIC TECHNIQUES, UROLOGICAL; HUMANS; INFANT, NEWBORN; URINARY TRACT INFECTIONS; VESICO-URETERAL REFLUX;

EID: 84859110102     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32834f0423     Document Type: Review

References (97)

1. Siomou E, Giapros V, Fotopoulos A, et al. Implications of99mTc-DMSA scintigraphy performed during urinary tract infection in neonates. Pediatrics 2009; 124:881-887.
2. Shaikh N, Morone NE, Bost JE, Farrell MH. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J 2008; 27:302-308. (Pubitemid 351483063)
3. Zorc JJ, Levine DA, Platt SL, et al. Clinical and demographic factors associated with urinary tract infection in young febrile infants. Pediatrics 2005; 116:644-648. (Pubitemid 44336681)
4. Kanellopoulos TA, Salakos C, Spiliopoulou I, et al. First urinary tract infection in neonates, infants and young children: a comparative study. Pediatr Nephrol 2006; 21:1131-1137. (Pubitemid 44083887)
5. Sastre JB, Aparicio AR, Cotallo GD, et al. Urinary tract infection in the newborn: clinical and radio imaging studies. Pediatr Nephrol 2007; 22:1735-1741. (Pubitemid 47337429)
6. Magin EC, Garcia-Garcia JJ, Sert SZ, et al. Efficacy of short-term intravenous antibiotic in neonates with urinary tract infection. Pediatr Emerg Care 2007; 23:83-86. (Pubitemid 46398938)
7. Ghaemi S, Fesharaki RJ, Kelishadi R. Late onset jaundice and urinary tract infection in neonates. Indian J Pediatr 2007; 74:139-141. (Pubitemid 47307256)
8. Tullus K. Difficulties indiagnosing urinary tract infections in small children. Pediatr Nephrol 2011; 26:1923-1926. This review gives recommendations, considering the exact diagnosis of UTI in children as a prerequisite for the comparability of future clinical studies.
9. Craig JC, Williams GJ, Jones M, et al. The accuracy of clinical symptoms and signs for the diagnosis of serious bacterial infection in young febrile children: prospective cohort study of 15 781 febrile illnesses. BMJ 2010; 340:c1594.
10. Mori R, LakhanpaulM, Verrier-Jones K.Diagnosis andmanagement of urinary tract infection in children: summary of NICE guidance. BMJ 2007; 335:395-397. (Pubitemid 47359319)
11. Wingerter S, Bachur R. Risk factors for contamination of catheterized urine specimens in febrile children. Pediatr Emerg Care 2011; 27:1-4. Physicians and nurses in a pediatric emergency department completed a survey after performing bladder catheterization of febrile children 36 months or younger. Infants younger than 6 months and uncircumcised boys are at increased risk of contaminated specimens from transurethral catheterization. A plea for bladder puncture in this age group.
12. Kozer E, Rosenbloom E, Goldman D, et al. Pain in infants who are younger than 2 months during suprapubic aspiration and transurethral bladder catheterization: a randomized, controlled study. Pediatrics 2006; 118:e51-e56. (Pubitemid 46071121)
13. Kotoula A, Gardikis S, Tsalkidis A, et al. Comparative efficacies of procalcitonin and conventional inflammatory markers for prediction of renal parenchymal inflammation in pediatric first urinary tract infection. Urology 2009; 73:782-786.
14. Doganis D, Siafas K, Mavrikou M, et al. Does early treatment of urinary tract infection prevent renal damage? Pediatrics 2007; 120:e922-e928. (Pubitemid 47549536)
15. Doganis D, Sinaniotis K. Early antibiotic treatment of pyelonephritis in children is still mandatory. Pediatrics 2009; 123:e173-e174; author reply e174.
16. Coulthard MG, Verber I, Jani JC, et al. Can prompt treatment of childhood UTI prevent kidney scarring? Pediatr Nephrol 2009; 24:2059-2063.
17. Brady PW, Conway PH, Goudie A. Length of intravenous antibiotic therapy and treatment failure in infants with urinary tract infections. Pediatrics 2010; 26:196-203. One of the few studies concerning the optimal length of parenteral antibacterial therapy in neonates and infants; however, a retrospective one, leaving some questions open.
18. Montini G, Zucchetta P, Tomasi L, et al. Value of imaging studies after a first febrile urinary tract infection in young children: data from Italian renal infection study 1. Pediatrics 2009; 123:e239-e246.
19. Miron D, Daas A, Sakran W, et al. Is omitting post urinary-tract- infection renal ultrasound safe after normal antenatal ultrasound? An observational study. Arch Dis Child 2007; 92:502-504. (Pubitemid 46867268)
20. Preda I, Jodal U, Sixt R, et al. Value of ultrasound in evaluation of infants with first urinary tract infection. J Urol 2010; 183:1984-1988. The study argues for ultrasound parameters (i.e., renal length, dilatation of the urinary tract) as first-line diagnostics in infants with first UTI.
21. Shiraishi K, Yoshino K, Watanabe M, et al. Risk factors for breakthrough infection in children with primary vesicoureteral reflux. J Urol 2010; 183:1527-1531.
22. Hansson S, Dhamey M, Sigstrom O, et al. Dimercapto-succinic acid scintigraphy instead of voiding cystourethrography for infants with urinary tract infection. J Urol 2004; 172:1071-1073; discussion 1073-1074.
23. Preda I, Jodal U, Sixt R, et al. Normal dimercaptosuccinic acid scintigraphy makes voiding cystourethrography unnecessary after urinary tract infection. J Pediatr 2007; 151:581-584; 584 e1.
24. Quirino IG, Silva JM, Diniz JS, et al. Combined use of late phase dimercaptosuccinic acid renal scintigraphy and ultrasound as first line screening after urinary tract infection in children. J Urol 2010; 185:258-263.
25. Subcommittee on Urinary Tract Infection SCoQIaM. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011; 128:595-610. The medical literature published after the last version of the guideline in 1999 was analyzed and used as the ground for evidence-based recommendations, including seven well founded statements.
26. Doganis D, Mavrikou M, Delis D, et al. Timing of voiding cystourethrography in infants with first time urinary infection. Pediatr Nephrol 2009; 24:319-322.
27. Sathapornwajana P, Dissaneewate P, McNeil E, Vachvanichsanong P. Timing of voiding cystourethrogram after urinary tract infection. Arch Dis Child 2008; 93:229-231. (Pubitemid 352025496)
28. Spencer JD, Bates CM, Mahan JD, et al. The accuracy and health risks of a voiding cystourethrogram after a febrile urinary tract infection. J Pediatr Urol 2010. [Epub ahead of print] A retrospective single-center review that shows no differences in results and complication rates between VCUGs performed within 1 week after UTI and those performed later.
29. Saadeh SA, Mattoo TK. Managing urinary tract infections. Pediatr Nephrol 2011; 26:1967-1976.
30. Preda I, Jodal U, Sixt R, et al. Imaging strategy for infants with urinary tract infection: a new algorithm. J Urol 2011; 185:1046-1052. Combining imaging with inflammatory parameters opens new diagnostic strategies and probably spares radiologic burden.
31. Leroy S, Romanello C, Galetto-Lacour A, et al. Procalcitonin to reduce the number of unnecessary cystographies in children with a urinary tract infection: a European validation study. J Pediatr 2007; 150:89-95. (Pubitemid 44940884)
32. Galanakis E, Bitsori M, Dimitriou H, et al. Urine interleukin-8 as amarker of vesicoureteral reflux in infants. Pediatrics 2006; 117:e863-e867. (Pubitemid 46071353)
33. Mantadakis E, Plessa E, Vouloumanou EK, et al. Serum procalcitonin for prediction of renal parenchymal involvement in children with urinary tract infections: a meta-analysis of prospective clinical studies. J Pediatr 2009; 155:875e1-881e1.
34. Bressan S, Andreola B, Zucchetta P, et al. Procalcitonin as apredictor of renal scarring in infants and young children. Pediatr Nephrol 2009; 24:1199-1204.
35. Leroy S, Romanello C, Galetto-Lacour A, et al. Procalcitonin is a predictor for high-grade vesicoureteral reflux in children: meta-analysis of individual patient data. J Pediatr 2011; 159:644-651 e4. A worthwhile overview about one of the most promising laboratory parameters for the detection of pyelonephritis and identification of children at risk for VUR by one of the most active working groups in this field.
36. Shim YH, Lee JW, Lee SJ. The risk factors of recurrent urinary tract infection in infants with normal urinary systems. Pediatr Nephrol 2009; 24:309-312.
37. Sjostrom S, Jodal U, Sixt R, et al. Longitudinal development of renal damage and renal function in infants with high grade vesicoureteral reflux. J Urol 2009; 181:2277-2283.
38. Dai B, Liu Y, Jia J, Mei C. Long-term antibiotics for the prevention of recurrent urinary tract infection in children: a systematic review and meta-analysis. Arch Dis Child 2010; 95:499-508. A nice meta-analysis of earlier and recent clinical studies in children, coming to the conclusion that there is no evidence that prophylactic antibiotics reduce the incidence of recurrent UTI in children. However, this statement should be regarded with suspicion: the review does not include current data from Gothenburg (see [46-48). Let us also wait for the forthcoming Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) data and carry out a new metaanalysis considering high-risk groups. It might come to a contrary conclusion.
39. Mori R, Fitzgerald A, Williams C, et al. Antibiotic prophylaxis for children at risk of developing urinary tract infection: a systematic review. Acta Paediatr 2009; 98:1781-1786.
40. Garin EH, Olavarria F, Garcia Nieto V, et al. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics 2006; 117:626-632. (Pubitemid 46063202)
41. Montini G, Rigon L, Zucchetta P, et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics 2008; 122:1064-1071.
42. Pennesi M, Travan L, Peratoner L, et al. Is antibiotic prophylaxis inchildren with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics 2008; 121:e1489-e1494.
43. Roussey-Kesler G, Gadjos V, Idres N, et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. J Urol 2008; 179:674-679; discussion 679.
44. Montini G, Hewitt I. Urinary tract infections: to prophylaxis or not to prophylaxis? Pediatr Nephrol 2009; 24:1605-1609.
45. Craig JC, Simpson JM, Williams GJ, et al. Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med 2009; 361:1748-1759.
46. Brandstrom P, Esbjorner E, Herthelius M, et al. The Swedish reflux trial in children. I: Study design and study population characteristics. J Urol 2010; 184:274-279. Published in one of the most important recent publications on antibacterial prophylaxis with dilating reflux in children. Antibacterial prophylaxis is efficient in children with dilating VUR.
47. Brandstrom P, Esbjorner E, Herthelius M, et al. The Swedish reflux trial in children. III: Urinary tract infection pattern. J Urol 2010; 184:286-291. Published in one of the most important recent publications on antibacterial prophylaxis with dilating reflux in children. Antibacterial prophylaxis is efficient in children with dilating VUR.
48. Brandstrom P, Neveus T, Sixt R, et al. The Swedish reflux trial in children. IV: Renal damage. J Urol 2010; 184:292-297. Published in one of the most important recent publications on antibacterial prophylaxis with dilating reflux in children. Antibacterial prophylaxis is efficient in children with dilating VUR.
49. Peters CA, Skoog SJ, Arant BS Jr, et al. Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol 2010; 184:1134-1144. By discriminating recommendations and options in reflux diagnosis and treatment, the new AUA guidelines provide individualized and differentiated strategies on an evidenced base. Unfortunately, these guidelines are limited to infants from 2 months onwards and not generally applicable to neonates.
50. Herndon CD. Antenatal hydronephrosis: differential diagnosis, evaluation, and treatment options. ScientificWorldJournal 2006; 6:2345-2365.
51. Herndon CD, Kitchens DM. The management of ureteropelvic junction obstruction presenting with prenatal hydronephrosis. ScientificWorldJournal 2009; 9:400-403.
52. Ulman I, Jayanthi VR, Koff SA. The long-term followup of newborns with severe unilateral hydronephrosis initially treated nonoperatively. J Urol 2000; 164:1101-1105. (Pubitemid 30637585)
53. Lee JH, Choi HS, Kim JK, et al. Nonrefluxing neonatal hydronephrosis and the risk of urinary tract infection. J Urol 2008; 179:1524-1528.
54. Walsh TJ, Hsieh S, Grady R, Mueller BA. Antenatal hydronephrosis and the risk of pyelonephritis hospitalization during the first year of life. Urology 2007; 69:970-974. (Pubitemid 46670239)
55. Song SH, Lee SB, Park YS, Kim KS. Is antibiotic prophylaxis necessary in infants with obstructive hydronephrosis? J Urol 2007; 177:1098-1101; discussion 1101.
56. Coelho GM, Bouzada MC, Lemos GS, et al. Risk factors for urinary tract infection in children with prenatal renal pelvic dilatation. J Urol 2008; 179:284-289. (Pubitemid 350225695)
57. Roth CC, Hubanks JM, Bright BC, et al. Occurrence of urinary tract infection in children with significant upper urinary tract obstruction. Urology 2009; 73:74-78.
58. Mami C, Paolata A, Palmara A, et al. Outcome and management of isolated moderate renal pelvis dilatation detected at postnatal screening. Pediatr Nephrol 2009; 24:2005-2008.
59. Mami C, Palmara A, Paolata A, et al. Outcome and management of isolated severe renal pelvis dilatation detected at postnatal screening. Pediatr Nephrol 2010; 25:2093-2097.
60. Islek A, Guven AG, Koyun M, et al. Probability of urinary tract infection in infants with ureteropelvic junction obstruction: is antibacterial prophylaxis really needed? Pediatr Nephrol 2011; 26:1837-1841.
61. Gimpel C, Masioniene L, Djakovic N, et al. Complications and long-term outcome of primary obstructive megaureter in childhood. Pediatr Nephrol 2010; 25:1679-1686. Although retrospectively calculating the obviously increased risk of UTI in obstructive megaureters, this study demonstrates the probable benefit of antibacterial prophylaxis with this uropathy frequently detected by neonatal screening.
62. Singh-Grewal D, Macdessi J, Craig J. Circumcision for the prevention of urinary tract infection in boys: a systematic review of randomised trials and observational studies. Arch Dis Child 2005; 90:853-858. (Pubitemid 41081370)
63. Montini G, Tullus K, Hewitt I. Febrile urinary tract infections in children. N Engl J Med 2011; 365:239-250. An expert view on urinary tract infections - an absolute must for everyone who wants to be informed about the currently most controversial topics in this field.
64. Adefurin A, Sammons H, Jacqz-Aigrain E, Choonara I. Ciprofloxacin safety in paediatrics: a systematic review [Review]. Arch Dis Child 2011; 96:874-880.
65. Bader MS, Hawboldt J, Brooks A. Management of complicated Urinary Tract Infections in the Era of Antimicrobial Resistance. Postgrad Med 2010; 122:7-15.
66. Bhat RG, Katy TA, Place FC. Pediatric Urinary Tract Infections. Emerg Med Clin North Am 2011; 29:637-.
67. Brady PW, Conway PH, Goudie A. Length of intravenous antibiotic therapy and treatment failure in infants with urinary tract infections. Pediatrics 2010; 126:196-203. [17]
68. Brandstrom P, Esbjorner E, Herthelius M, et al. The Swedish reflux trial in children. I: Study design and study population characteristics. J Urol 2010; 184:274-279. [46]
69. Brandstrom P, Esbjorner E, Herthelius M, et al. The Swedish reflux trial in children. III: Urinary tract infection pattern. J Urol 2010; 184:286-291. [47]
70. Brandstrom P, Neveus T, Sixt R, et al. The Swedish reflux trial in children. IV: Renal damage. J Urol 2010; 184:292-297. [48]
71. Buhr GT, Genao L,White HK. Urinary Tract Infections in Long- Term Care Residents. Clin Geriatr Med 2011; 27:229-.
72. Chenoweth CE, Saint S. Urinary Tract Infections. Infect Dis Clin North Am 2011; 25:103-.
73. Dai B, Liu Y, Jia J, Mei C. Long-term antibiotics for the prevention of recurrent urinary tract infection in children: a systematic review and meta-analysis. Arch Dis Child 2010; 95:499-508. [38]
74. Damiano R, Quarto G, Bava I, Ucciero G, et al. Prevention of Recurrent Urinary Tract Infections by Intravesical Administration of Hyaluronic Acid and Chondroitin Sulphate: A Placebo-Controlled Randomised Trial. Eur Urol 2011; 59:645-651.
75. de Jesus LE, Fernandes A, Sias SMA, de Mello CMG, et al. Neonatal Osteomyelitis and Complex Nephro-Ureteral Duplication. Surg Infect 2011; 12:73-75.
76. Gimpel C, Masioniene L, Djakovic N, et al. Complications and long-term outcome of primary obstructive megaureter in childhood. Pediatr Nephrol 2010; 25:1679-1686. [61]
77. Hsueh PR, Hoban DJ, Carmeli Y, Chen SY, et al. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region [Review]. J Infect 2011; 63:114-123.
78. Leroy S, Romanello C, Galetto-Lacour A, et al. Procalcitonin is apredictor for high-grade vesicoureteral reflux in children: meta-analysis of individual patient data. J Pediatr 2011; 159:644-651 e4. [35]
79. Lin YC, Lin HC. Doctor characteristics and prescribing antibiotics for urinary tract infections: the experience of an Asian country. J Eval Clin Pract 2010; 16:1221-1226.
80. Montini G,Tullus K, Hewitt I. Febrile urinary tract infections in children. N Engl J Med 2011; 365:239-250. [63]
81. Nicoletti J, Kuster SP, Sulser T, Zbinden R, et al. Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland - art. no. w13059. Swiss Med Wkly 2010:13059.
82. No Authors Given. Subcommittee on Urinary Tract Infection SCoQIaM. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011; 128:595-610. [25]
83. Papasotiriou M, Savvidaki E, Kalliakmani P, Papachristou E, et al. Predisposing Factors to the Development of Urinary Tract Infections in Renal Transplant Recipients and the Impact on the Long-Term Graft Function. Ren Fail 2011; 33:405-410.
84. Peters CA, Skoog SJ, Arant Jr BS, et al. Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol 2010; 184:1134-1144. [49]
85. Preda I, Jodal U, Sixt R, et al. Imaging strategy for infants with urinary tract infection: a new algorithm. J Urol 2011; 185:1046-1052. [30]
86. Preda I, Jodal U, Sixt R, et al. Value of ultrasound in evaluation of infants with first urinary tract infection. J Urol 2010; 183:1984-1988. [20]
87. Ramlakhan SL, Burke DP, Goldman RS. Dipstick urinalysis for the emergency department evaluation of urinary tract infections in infants aged less than 2 years. Eur J Emerg Med 2011; 18:221-224.
88. Redman R, Damiao R, Kotey P, Kaniga K, et al. Safety and Efficacy of intravenous Doripenem for the Treatment of Complicated Urinary Tract Infections and Pyelonephritis. J Chemother 2010; 22:384-391.
89. Rosenthal VD, Dwivedy A, Calderon MER, Esen S, et al. Time-dependent analysis of length of stay and mortality due to urinary tract infections in ten developing countries: INICC findings. J Infect 2011; 62:136-141.
90. Ruan JM, Adams SR, Carpinito G, Ferzandi TR. Bladder Calculus Presenting as Recurrent Urinary Tract Infections: A Late Complication of Cervical Cerclage Placement A Case Report. J Reprod Med 2011; 56:172-174.
91. Spencer JD, Bates CM, Mahan JD, et al. The accuracy and health risks of a voiding cystourethrogram after a febrile urinary tract infection. J Pediatr Urol 2010. [Epub ahead of print] [28]
92. Traxel E, De FoorW, Minevich E, Reddy P, et al. Low Incidence of urinary Tract Infections Following Renal Transplantation in ChildrenWith Bladder Augmentation. J Urol 2011; 186:667-671.
93. Tullus K. Difficulties indiagnosing urinary tract infections in small children. Pediatr Nephrol 2011; 26:1923-1926. [08]
94. van den Heijkant M, Haider N, Taylor C, Subramaniam R. Efficacy of bladder irrigation and surveillance program in prevention of urinary tract infections and bladder calculi in children with an ileocystoplasty and bladder neck repair. Pediatr Surg Int 2011; 27:781-785.
95. Vazquez JC, Abalos E. Treatments for symptomatic urinary tract infections during pregnancy - art. no. CD002256 [Review]. Cochrane Database of Systematic Reviews 2011:2256.
96. Wagenlehner FME, Schmiemann G, Hoyme U, Funfstuck R, et al. National S3guideline on uncomplicated urinary tract infection. Recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients [German]. Urologe 2011:153.
97. Wingerter S, Bachur R. Risk factors for contamination of catheterized urine specimens in febrile children. Pediatr Emerg Care 2011; 27:1-4. [11]